MRVFF / Miravo Healthcare™ to Present at Q1 Virtual Investor Summit

Nuvo Pharmaceuticals Inc. (OTCQX:MRVFF) Q3 2022 Earnings Conference Call November 14, 2022 11:00 AM ET Company Participants Jesse Ledger – President more_horizontal

Nuvo Pharmaceuticals Inc. (MRVFF) CEO Jesse Ledger on Q4 2021 Results - Earnings Call Transcript more_horizontal

Tuesday, March 8, 2022 - 2:00 p.m. ETMississauga, Ontario--(Newsfile Corp. - February 28, 2022) - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) more_horizontal

Tuesday, March 8, 2022 - 2:00 p.m. ETMississauga, Ontario--(Newsfile Corp. - February 28, 2022) - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) more_horizontal

Tuesday, March 8, 2022 - 2:00 p.m. ETMississauga, Ontario--(Newsfile Corp. - February 28, 2022) - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) more_horizontal

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-fo more_horizontal

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-fo more_horizontal

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-fo more_horizontal